Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-10 Purchase | 2026-02-17 9:14 pm | Ernexa Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 4,000,000 | $0.5 | $2,000,000 | 10,779,440 (Direct) | View |
| 2025-06-09 Purchase | 2025-06-11 8:34 pm | Ernexa Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 21,241,163 | $0.1046 | $2,221,826 | 41,659,743 (Direct) | View |
| 2024-09-24 Purchase(A) | 2025-05-07 11:48 am | Ernexa Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 13,252,112 | $0 | $0 | 13,808,577 (Direct) | View |
| 2025-04-02 Purchase | 2025-04-04 10:54 am | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 3,768,397 | $0.1046 | $394,174 | 20,401,602 (Direct) | View |
| 2024-10-29 Purchase | 2024-11-05 12:42 pm | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 13,252,112 | $0 | $0 | 29,823,881 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-08-31 Option Award | 2026-09-01 9:59 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Bristol James Arthur Director | 13,403 | $0 | 13,403 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-01 9:56 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Cicala Peter Director | 11,026 | $0 | 11,026 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-01 9:49 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Polinsky David Director | 5,083 | $0 | 5,083 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-01 9:48 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Wexler William A. Director | 5,943 | $0 | 5,943 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-01 9:47 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Ratner Elena Director | 5,944 | $0 | 5,944 (Direct) | View |
| 2026-08-31 Option Award | 2026-09-01 9:46 pm | N/A 2036-08-31 | Ernexa Therapeutics Inc. | ERNA | Luther Sanjeev President and CEO | 118,848 | $0 | 118,848 (Direct) | View |
Ownership | 2026-08-27 7:52 pm | N/A N/A | Ernexa Therapeutics Inc. | ERNA | Polinsky David Director | 0 | $0 | 16,000 (Indirect) | View |
| 2025-06-21 Exercise | 2025-07-07 8:00 pm | N/A N/A | Ernexa Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 30 | $0 | 110 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Wexler William A. Director | 124,533 | $0 | 124,533 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 150,000 | $0 | 150,000 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Bristol James Arthur Director | 72,074 | $0 | 72,074 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Cicala Peter Director | 51,485 | $0 | 51,485 (Direct) | View |
| 2025-02-07 Option Award | 2025-02-10 7:00 pm | N/A 2035-02-07 | Eterna Therapeutics Inc. | ERNA | Luther Sanjeev President & CEO | 1,123,350 | $0 | 1,123,350 (Direct) | View |
| 2025-01-13 Option Award | 2025-01-14 5:01 pm | N/A 2035-01-13 | Eterna Therapeutics Inc. | ERNA | Ratner Elena Director | 140,078 | $0 | 140,078 (Direct) | View |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,819,546 | $0.5 | 29,823,881 (Direct) | View |
| 2024-10-29 Conversion | 2024-11-05 12:42 pm | N/A 2025-09-24 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 1,368,626 | $0 | 29,823,881 (Direct) | View |
| 2024-06-21 Tax Withholding | 2024-06-25 4:32 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 180 | $1.94 | 1,622 (Direct) | View |
| 2024-06-21 Exercise | 2024-06-25 4:32 pm | N/A N/A | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 437 | $0 | 1,622 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:31 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Cicala Peter Director | 88,946 | $0 | 88,946 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:30 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Gurrola Sandra M Sr. VP of Finance | 80,000 | $0 | 80,000 (Direct) | View |
| 2024-04-26 Option Award | 2024-04-29 4:30 pm | N/A 2034-04-26 | Eterna Therapeutics Inc. | ERNA | Bristol James Arthur Director | 124,525 | $0 | 124,525 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:02 pm | N/A 2034-01-01 | Eterna Therapeutics Inc. | ERNA | Luther Sanjeev President and CEO | 1,685,218 | $0 | 1,685,218 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-03 5:01 pm | N/A 2034-01-01 | Eterna Therapeutics Inc. | ERNA | Clarke Dorothy J General Counsel Director | 168,521 | $0 | 168,521 (Direct) | View |
| 2023-12-14 Expired | 2023-12-20 10:05 am | 2023-07-14 2028-07-14 | Eterna Therapeutics Inc. | ERNA | Cherington Charles 10% Owner | 2,831,204 | $0 | 8,957,180 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 9:38 pm | 2023-06-02 2028-06-02 | Eterna Therapeutics Inc. | ERNA | Freebird Partners LP Freebird Investments LLC HUFF CURTIS W 10% Owner | 949,402 | $0 | 5,622,833 (Direct) | View |